COAGULATION CONTROL CONTAINING HEMOGLOBIN— 510(k) K925340

Name: FDA 510(k) clearance K925340
Creator: U.S. Food and Drug Administration
Published: 1993-03-23

Substantially Equivalent

Analytical Control Systems, Inc.

FDA 510(k) clearance K925340 for COAGULATION CONTROL CONTAINING HEMOGLOBIN, Substantially Equivalent on 1993-03-23. Applicant: Analytical Control Systems, Inc.. Device class: 2.

Clearance details

Applicant: Analytical Control Systems, Inc.
Product code: Code JPA
Device class: Class 2
Regulation: 21 CFR 864.5425
Advisory panel: Hematology
Date received: 1992-10-20
Decision date: 1993-03-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JPA

view all

K253658 — STA Satellite Max®2026-04-27
K250965 — Automated Blood Coagulation Analyzer CN-Series (CN-6000)2025-06-02
K251024 — TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge2025-04-30
K243858 — TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge2025-01-15
K232018 — Citrated: K, KH, RTH, FFH2024-03-29

More clearances from Analytical Control Systems, Inc.

view all

K961892 — SPECKTIN-LA TEST SET1997-03-07
K941115 — ACS CARDIO-TROL CONTROL1994-07-20
K940272 — ACS NORMAL ANGIOTENSIN CONVERTING ENZYME CONTROL1994-04-20
K940397 — ACS O DILVENT PROTEIN DILUTION MATRIX1994-03-11
K930477 — ACS ANGIOTENSIN CONVERTING ENZYME (ACE) CALIBRATOR1993-06-07

Adverse events under product code JPA

product code JPA

Death: 6
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.